Show simple item record

dc.contributor.authorMeyerson, Beth E
dc.contributor.authorLawrence, Carrie A
dc.contributor.authorCope, Summer Dawn
dc.contributor.authorLevin, Steven
dc.contributor.authorThomas, Christopher
dc.contributor.authorEldridge, Lori Ann
dc.contributor.authorColes, Haley B
dc.contributor.authorVadiei, Nina
dc.contributor.authorKennedy, Amy
dc.date.accessioned2020-04-15T18:19:17Z
dc.date.available2020-04-15T18:19:17Z
dc.date.issued2019-09-18
dc.identifier.citationMeyerson, B.E., Lawrence, C.A., Cope, S.D. et al. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018. Harm Reduct J 16, 57 (2019). https://doi.org/10.1186/s12954-019-0327-1en_US
dc.identifier.issn1477-7517
dc.identifier.pmid31533730
dc.identifier.doi10.1186/s12954-019-0327-1
dc.identifier.urihttp://hdl.handle.net/10150/641001
dc.description.abstractBackground: Community pharmacies are important for health access by rural populations and those who do not have optimum access to the health system, because they provide myriad health services and are found in most communities. This includes the sale of non-prescription syringes, a practice that is legal in the USA in all but two states. However, people who inject drugs (PWID) face significant barriers accessing sterile syringes, particularly in states without laws allowing syringe services programming. To our knowledge, no recent studies of pharmacy-based syringe purchase experience have been conducted in communities that are both rural and urban, and none in the Southwestern US. This study seeks to understand the experience of retail pharmacy syringe purchase in Arizona by PWID. Methods: An interview study was conducted between August and December 2018 with 37 people living in 3 rural and 2 urban Arizona counties who identified as current or former users of injection drugs. Coding was both a priori and emergent, focusing on syringe access through pharmacies, pharmacy experiences generally, experiences of stigma, and recommendations for harm reduction services delivered by pharmacies. Results: All participants reported being refused syringe purchase at pharmacies. Six themes emerged about syringe purchase: (1) experience of stigma and judgment by pharmacy staff, (2) feelings of internalized stigma, (3) inconsistent sales outcomes at the same pharmacy or pharmacy chain, (4) pharmacies as last resort for syringes, (5) fear of arrest for syringe possession, and (6) health risks resulting from syringe refusal. Conclusions: Non-prescription syringe sales in community pharmacies are a missed opportunity to improve the health of PWID by reducing syringe sharing and reuse. Yet, current pharmacy syringe sales refusal and stigmatization by staff suggest that pharmacy-level interventions will be necessary to impact pharmacy practice. Lack of access to sterile syringes reinforces health risk behaviors among PWID. Retail syringe sales at pharmacies remain an important, yet barrier-laden, element of a comprehensive public health response to reduce HIV and hepatitis C among PWID. Future studies should test multilevel evidence-based interventions to decrease staff discrimination and stigma and increase syringe sales.en_US
dc.language.isoenen_US
dc.publisherBMCen_US
dc.rightsCopyright © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHIVen_US
dc.subjecthepatitis cen_US
dc.subjectStigmaen_US
dc.subjectSyringe accessen_US
dc.titleI could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018en_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Southwest Inst Res Womenen_US
dc.contributor.departmentUniv Arizona, Coll Pharmen_US
dc.identifier.journalHARM REDUCTION JOURNALen_US
dc.description.noteOpen access journalen_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal published versionen_US
dc.source.journaltitleHarm reduction journal
dc.source.volume16
dc.source.issue1
dc.source.beginpage57
dc.source.endpage
refterms.dateFOA2020-04-15T18:19:19Z
dc.source.countryEngland


Files in this item

Thumbnail
Name:
s12954-019-0327-1.pdf
Size:
605.9Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Except where otherwise noted, this item's license is described as Copyright © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.